Synthesis, Characterization and Biochemical Activity of Homo and Heterobimetallic Derivatives of Dibutyltin Containing Mixed Chelating Ligands

Bu2Sn(OPri)2's interaction with Schiff base (LaH), where La = L1 = OC6H4CH=NCNSC6H4 (1) and La = L2 = O2NC6H4CH=NCH2CH2O (2) yields the precursor derivatives Bu2Sn(La)(OPri), which on equimolar reaction with glycol (HOGOH), where G = G1 = OCH(Me)CH(Me)O, and G = G2 = OC(Me)2C(Me)2O, and diethanolamine RN(CH2CH2OH)2 yield the derivative of the type Bu2Sn(La)(LbH) [where La = L1, Lb = G1 (3); La = L1, Lb = G2 (4); La = L2, Lb = G1 (5); La = L2, Lb = G2 (6); La = L1, Lb = RN(CH2CH2O)2 where R=H(7); La = L1, Lb = RN(CH2CH2O)2 where R=CH3(8); La = L2, Lb = RN(CH2CH2O)2 where R=H(9); La = L2, Lb = RN(CH2CH2O)2 where R= CH3(10)]. Homometallic mixed ligand derivatives (3)-(10) on 1:1 reaction with aluminium isopropoxide form monomeric heterobimetallic mixed chelating ligand derivatives of type [Bu2Sn(La)(LbAl(OPri)2] (11)-(18) respectively. All these derivatives have been characterized by elemental analysis and spectroscopic [IR, NMR 1H, 119Sn, and 27Al ] studies. The synthesized derivatives were screened for their in vitro antimicrobial activity against gram +ve bacteria i.e.S.aureus and gram -ve bacteria i.e. E.Coli. All the derivatives showed enhanced antimicrobial activity than the present ligands.

Authors

Institutions

Publication Details

Journal
Journal of Advanced Chemical Sciences
Published
2024-09-06
DOI
https://doi.org/10.30799/jacs.259.24100301
Citations
1
Primary Topic
Organometallic Compounds Synthesis and Characterization
Type
article
Field-Weighted Citation Impact
0.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis, Characterization and Biochemical Activity of Homo and Heterobimetallic Derivatives of Dibutyltin Containing Mixed Chelating Ligands

Nandu Bala Sharma, Yogesh Kumar Gupta
1 citations
Journal of Advanced Chemical Sciences
Organometallic Compounds Synthesis and Characterization
0.25
article

Synthesis, Characterization and Biochemical Activity of Homo and Heterobimetallic Derivatives of Dibutyltin Containing Mixed Chelating Ligands

Nandu Bala Sharma, Yogesh Kumar Gupta
article en
1 citations

Abstract

Bu2Sn(OPri)2's interaction with Schiff base (LaH), where La = L1 = OC6H4CH=NCNSC6H4 (1) and La = L2 = O2NC6H4CH=NCH2CH2O (2) yields the precursor derivatives Bu2Sn(La)(OPri), which on equimolar reaction with glycol (HOGOH), where G = G1 = OCH(Me)CH(Me)O, and G = G2 = OC(Me)2C(Me)2O, and diethanolamine RN(CH2CH2OH)2 yield the derivative of the type Bu2Sn(La)(LbH) [where La = L1, Lb = G1 (3); La = L1, Lb = G2 (4); La = L2, Lb = G1 (5); La = L2, Lb = G2 (6); La = L1, Lb = RN(CH2CH2O)2 where R=H(7); La = L1, Lb = RN(CH2CH2O)2 where R=CH3(8); La = L2, Lb = RN(CH2CH2O)2 where R=H(9); La = L2, Lb = RN(CH2CH2O)2 where R= CH3(10)]. Homometallic mixed ligand derivatives (3)-(10) on 1:1 reaction with aluminium isopropoxide form monomeric heterobimetallic mixed chelating ligand derivatives of type [Bu2Sn(La)(LbAl(OPri)2] (11)-(18) respectively. All these derivatives have been characterized by elemental analysis and spectroscopic [IR, NMR 1H, 119Sn, and 27Al ] studies. The synthesized derivatives were screened for their in vitro antimicrobial activity against gram +ve bacteria i.e.S.aureus and gram -ve bacteria i.e. E.Coli. All the derivatives showed enhanced antimicrobial activity than the present ligands.

Journal of Advanced Chemical SciencesVol. 10(3)
Banasthali University (IN)
Openalex Percentile: Top 49%
Organometallic Compounds Synthesis and Characterization
0.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.